search button

Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis stages

  • Authors:
    • Fei Xu
    • Pengliang Xu
    • Wenqiang Cui
    • Weiyi Gong
    • Ying Wei
    • Baojun Liu
    • Jingcheng Dong

  • View Affiliations

  • Published online on: May 7, 2018     https://doi.org/10.3892/ol.2018.8644
  • Pages: 483-490
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to identify a high‑risk population with non‑small cell lung cancer (NSCLC) and to predict TNM stages using the neutrophil‑to‑lymphocyte ratio (NLR) and the platelet‑to‑lymphocyte ratio (PLR). This retrospective study included preoperative data of 171 patients and 105 controls. Compared with healthy controls, patients with NSCLC had higher levels of NLR and PLR (NLR, 2.719±0.183 vs. 1.813±0.079, P<0.01; PLR, 135.800±4.778 vs. 112.000±5.651, P<0.01, respectively). The associations between Tumor‑Node‑Metastasis stages and the aforementioned parameters were detected (both P<0.01). NLR and PLR improved the rate of early diagnosis of NSCLC, particularly for stages III and IV with a higher area under curve value (0.752 and 0.759, respectively) compared with stage I and II NSCLC. In addition, PLR with a T stage‑dependent increase may be a potential and independent predictive marker for T stage (P<0.05); the NLR exhibited an N stage‑dependent increase (except for stage N3) and was identified as a marker for N stage (P<0.0001). It was subsequently concluded that NLR and PLR are useful biomarkers in the early diagnosis of NSCLC; that these two parameters were capable of indicating advanced stages, III and IV; and that PLR and NLR were independent predictors for T and N stages, respectively.
View Figures
View References

Related Articles

Journal Cover

July-2018
Volume 16 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Xu F, Xu P, Cui W, Gong W, Wei Y, Liu B and Dong J: Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis stages. Oncol Lett 16: 483-490, 2018
APA
Xu, F., Xu, P., Cui, W., Gong, W., Wei, Y., Liu, B., & Dong, J. (2018). Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis stages. Oncology Letters, 16, 483-490. https://doi.org/10.3892/ol.2018.8644
MLA
Xu, F., Xu, P., Cui, W., Gong, W., Wei, Y., Liu, B., Dong, J."Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis stages". Oncology Letters 16.1 (2018): 483-490.
Chicago
Xu, F., Xu, P., Cui, W., Gong, W., Wei, Y., Liu, B., Dong, J."Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis stages". Oncology Letters 16, no. 1 (2018): 483-490. https://doi.org/10.3892/ol.2018.8644